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ABSTRACT 22 
Long-term peritoneal dialysis often ends up with ultrafiltration failure (UFF) which is 23 
partially caused by persistent inflammation and fibrosis of peritoneal tissues. However, 24 
the mechanism is still unclear. In the current study, the peritoneum from UFF patients 25 
demonstrated inflammation and fibrosis which were positively related to expression of 26 
VEGFA. The in vitro model using human peritoneal mesothelial cells (HPMCs) stim-27 
ulated by high glucose or advanced glycation end (AGE) product showed consistent 28 
changes of inflammation, fibrosis and VEGFA. What’s more, we showed that VEGFA 29 
was an instigator of inflammation and fibrosis. Several miRNAs have been reported to 30 
regulate expression of VEGFA elsewhere. Five of them were selected to test the ex-31 
pression in peritoneum of PD patients. Results suggested that miR-15a-5p was the most 32 
significantly down-regulated one. Also, in high glucose or AGE product -stimulated 33 
HPMCs, miR-15a-5p decreased. When miRNA mimic was used to restore the expres-34 
sion of miR-15a-5p, high glucose-induced VEGFA was repressed. The predicted bind-35 
ing site between these two molecules was confirmed by dual-luciferase assay. Restora-36 
tion of miR-15a-5p restrained inflammation and fibrosis of HMPCs. TGF-β1/Smad2 37 
was shown to be the down-stream signaling pathway and their activity was regulated 38 
by miR-15a-5p/VEGFA. In conclusion, our present study demonstrates that miR-15a-39 
5p acts as a regulator of VEGFA mRNA and the following inflammation and fibrosis 40 
in peritoneal mesothelial cells. The miR-15a-5p/VEGFA pathway may be a potential 41 
target for preventing ultrafiltration failure in peritoneal dialysis patients. 42 
INTRODUCTION 43 
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Ultrafiltration failure (UFF) caused by peritoneal fibrosis (PF) is currently a challenge 44 
for peritoneal dialysis (PD). UFF has been the leading cause of PD dropping out and 45 
has been closely associated with patients’ survival (Chemek et al., 2018). Several fac-46 
tors, including inflammatory cell infiltration, neoangiogenesis, mesothelial-mesenchy-47 
mal transition and interstitial fibrosis (mainly caused by extracellular matrix deposition), 48 
play important roles in UFF (Jiang et al., 2018). Of all these, inflammation and fibrosis 49 
are believed to be directly associated with UFF and therefore obtained most attentions 50 
(Davies, 2016). The normal function of peritoneal membrane is essential for the ac-51 
ceptance of PD (Margetts and Bonniaud, 2003). Mesothelial cell, covering the surface 52 
of peritoneal membrane, is the first barrier to PD solution. Various ingredients, espe-53 
cially high concentration of glucose, could induce injury to mesothelial cells. Such 54 
damage, accompanied with inflammation, may lead to fibrosis and, consequently, de-55 
creased efficiency of PD (Krediet et al., 2000). Also, it has been reported that long-term 56 
exposure to high concentration of glucose could lead to deposition of advanced gly-57 
cation end (AGE) product (Kawanishi et al., 2013). The accumulation of AGE product 58 
could also be a risk factor for UFF. It has been shown that a reduction in AGE product 59 
relieved PD (Honda et al., 1999). 60 
Vascular endothelial growth factor (VEGF) is a family of proteins that was initially 61 
reported to promote the formation of vascular endothelial cells. Seven members have 62 
been identified in the family, and of which, VEGFA is the most ubiquitously and abun-63 
dantly expressed member. Previous studies have indicated that over-expressed VEGF 64 
is closely related to PF and UFF (Liu et al., 2018; Tang, 2017). However, its role and 65 
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related mechanism in peritoneal mesothelial cells need to be further verified. 66 
MicroRNAs, a class of endogenous non-coding small RNAs in eukaryotes, are about 67 
20-22 nucleotides in length and regulate the expression of target genes at post-tran-68 
scriptional level. By completely or incompletely pairing with bases in the 3’UTR of 69 
target mRNAs, miRNAs facilitate degradation of target mRNAs, inhibits translation, 70 
therefore influence cell growth, differentiation, apoptosis and tumorigenesis (Guan et 71 
al., 2016). Several miRNAs have been reported to regulate VEGFA mRNA in different 72 
conditions(Aqeilan et al., 2010). However, the functional one in mesothelial cells dur-73 
ing UFF has yet to be known.  74 
Evidence from literature showed that TGF-β1/Smad2 play central roles in regulating 75 
extracellular matrix accumulation of HPMCs and fibrosis of peritoneum (Yao et al., 76 
2007). Here we tested their involvement in VEGFA function of high glucose stimulated 77 
HPMCs. 78 
In this study, both human peritoneal tissues and cultured mesothelial cells were used to 79 
investigate the role of VEGFA in process of peritoneal inflammation and fibrosis. Then 80 
the putative regulatory miRNA for VEGFA was discussed. Potential signaling pathway 81 
was evaluated. Our study will provide novel evidence to the mechanism of peritoneum 82 
fibrosis and inflammation caused by PD which may inspirit potential therapeutic target 83 
for preventing UFF.  84 
 85 
MATERIALS AND METHODS 86 
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Tissue collection 87 
All human peritoneal tissues were collected from the First Affiliated Hospital of Zheng-88 
zhou University. Normal peritoneal tissues were excision redundant of abdominal sur-89 
gical. PD samples were collected from extubating procedure of patients with peritoneal 90 
ultrafiltration failure. PD duration of all these patients was at least 3.5 years. These 91 
investigations were conducted in accordance with the principles of the Declaration of 92 
Helsinki and were approved by the Research Ethics Committee of Zhengzhou Univer-93 
sity. Informed consent has been obtained from each patient. 94 
Tissue staining 95 
The standard tissues embedded in paraffin were sectioned at 4 μm. Hematoxylin-eosin 96 
(HE), Periodic Acid-Schiff (PAS) and Masson staining were carried out as previously 97 
described (Li et al., 2017; Otali et al., 2016). The fibrosis degree was assessed by two 98 
independent investigators (Q. H and L. S) according to the thickness and compactness 99 
of fiber. The final score was the average value. 100 
Cell culture 101 
Human peritoneal mesothelial cells (HPMCs) were a generous gift of Professor 102 
Zongpei Jiang from Sixth Affiliated Hospital of Sun Yat-sen University. DMEM/F12 103 
medium was used for cell culture, and the cultural procedure was carried out as previ-104 
ously described (Shang et al., 2017). High glucose (concentration at 75 or 125 mmol/L 105 
in cultural medium) was used as a stimulator and mannitol of the same concentration 106 
was used as an osmolality control. AGE product at concentration of 50 or 100μg/mL 107 
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was also used in our experiment.  108 
Western blotting 109 
All the procedures were performed as described previously (Zhu et al., 2018). Briefly, 110 
cell lysate was extracted using RIPA buffer (CWBiotech Co., Beijing, China), and the 111 
concentration was measured using BCA protein assay kit (CWBiotech Co., Beijing, 112 
China). Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 113 
performed before protein was transferred to polyvinylidene fluoride (PVDF) mem-114 
branes (Roche, Mannheim, Germany). The membranes were blocked using 3% de-fat 115 
milk shaking for 2 hours at room temperature. After that, they were incubated with 116 
primary antibodies at 4°C overnight and secondary antibody at room temperature for 2 117 
hours. Enhanced chemiluminescence reagent kit (CWBiotech Co., Beijing, China) was 118 
used to detect the bands. Primary antibodies of anti-VEGFA (1:1000, ProteinTech 119 
Group, Chicago, IL), anti-Collagen IV, anti-Fibronectin (1:1000, Abcam, Cambridge, 120 
MA), anti-Smad2 (1:1000, Cell Signaling Technology, Danvers, MA), anti-p-Smad2 121 
(1:1000, Cell Signaling Technology, Danvers, MA) and anti-GAPDH (1:1000, Cell 122 
Signaling Technology, Danvers, MA) were used in this study. Secondary antibodies 123 
(Dingguo Changsheng Biotech Co., Ltd.) were used at 1:1000 dilution. 124 
Real-time PCR 125 
Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) as 126 
described previously (Xiao et al., 2015). Expression of miRNAs was measured by miR 127 
qRT-PCR Quantitation Kit (Novland BioPharma, Shanghai, China) according to the 128 
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manufacturer’s instruction. Reverse transcription of mRNA was taken out using HiS-129 
cript Q RT SuperMix for qPCR (Vazyme, Nanjing, China) and expression of VEGFA 130 
mRNA was measured by AceQTM qPCR SYBR Green Master Mix (Novland Bio-131 
Pharma, Shanghai, China). Primers for mRNA detection: VEGFA F: 5'-132 
CTAATGTTATTGGTGTCTTCA-3'; R: 5'-TCTCATCTCCTCCTCTTC-3'; GAPDH 133 
F: 5’-CTCTGGTAAAGTGGATATTGT-3’; R: 5’-GGTGGAATCATATTGGAACA-134 
3’. 135 
Enzyme-linked immunosorbent assay  136 
Tissue homogenate or the supernatant of treated cells were collected and stored at 137 
−80°C. Concentrations of VEGFA (Abcam, Cambridge, MA), interleukin (IL) -6 138 
(Thermo Fisher Scientific, USA), monocyte chemotactic protein (MCP) -1 (Abcam, 139 
Cambridge, MA), transforming growth factor (TGF) -β1 (Abcam, Cambridge, MA), 140 
IL-17a (Abcam, Cambridge, MA), TNF-α (Abcam, Cambridge, MA) and IL-8 (Thermo 141 
Fisher Scientific, USA) were measured by Enzyme-linked immunosorbent assay 142 
(ELISA) according to the manufacturer’s instruction. 143 
Cell transfection 144 
MiRNA mimic targeting miR-15a-5p and siRNA targeting VEGFA were synthesized 145 
by RiboBio Co. (Guangzhou, China). The oligodeoxynucleotide sequences used in this 146 
study were as follows: miR-15a-5p mimic: Sense: 5’-UAGCAGCACAU-147 
AAUGGUUUGUG-3’; Anti-sense: 5’-CACAAACCAUUAUGUGCUGCUA-3’; 148 
miR-15a-5p inhibitor: 5’-CACAAACCAUUAUGUGCUGCUA-3’. SiRNA for 149 
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VEGFA: 5’-GGAGTACCCTGATGAGATC-3’. Lipofectamine 2000 (GenePharma, 150 
Shanghai, China) was used for transfection as previously described (Schneider et al., 151 
2017). Transfection efficiency was measured by RT-PCR or western blotting. 152 
Dual-luciferase reporter assay 153 
To test the direct binding ability between miR-15a-5p and VEGFA mRNA, we per-154 
formed dual-luciferase reporter assay. The predicted binding sequence was identified 155 
and downloaded from TargetScan (http://www.targetscan.org). Recombinant pmir-156 
GLO plasmid containing binding sequence was constructed by GenePharma (Shanghai, 157 
China). Enzyme activity was measured by Luciferase Reporter Assay System (Promega, 158 
Madison, WI) according to the manufacturer’s instruction.  159 
Statistical analysis 160 
Statistical analysis was performed using SPSS 21.0 software (SPSS Inc., Chicago, IL, 161 
USA). Data are expressed as mean ± standard deviation (SD). The difference in mean 162 
values between different groups was examined using one-way ANOVA followed by 163 
Duncan’s multiple range test. Pearson correlation coefficient was calculated to analyze 164 
correlation between two data sets. A P value < 0.05 at two-tailed was considered as 165 
statistically significant. 166 
RESULTS  167 
Fibrosis and inflammation in peritoneum of long-term PD patients were associ-168 
ated with increased VEGFA 169 
HE, PAS and Masson staining showed that compact and thick fibrotic tissues were only 170 
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found in patients with long-term PD, but not in controls (Figure 1 A). Summarized data 171 
indicated that, peritoneum of PD group showed different degrees of fibrosis (Figure 1 172 
B). Expression of VEGFA was semi-quantitatively measured by ELISA and results 173 
showed that it was increased in PD group (Figure 1 C). To further evaluate the role of 174 
VEGFA in peritoneal fibrosis, we performed the correlation analysis. It was indicated 175 
that higher level of VEGFA was closely related with aggravated fibrosis of peritoneal 176 
tissues (Figure 1 D). Then we measured the expression of inflammatory factors includ-177 
ing IL-6, MCP-1, TGF-β1 and IL-8 in the supernatant of tissue homogenate by ELISA 178 
and results showed that all these proteins were significantly increased in PD group (Fig-179 
ure 2 A). We also estimated their correlation with VEGFA. Results indicated that higher 180 
level of VEGFA was closely related with increased inflammatory factors of peritoneal 181 
tissues (Figure 2 B). These results together suggested that peritoneal inflammation and 182 
fibrosis in long-term PD patients were closely related with over-expressed VEGFA. 183 
Over-expressed VEGFA was related with fibrosis and inflammation in cultured 184 
HPMCs 185 
HPMCs were cultured in vitro and stimulated by either high glucose or AGE product at 186 
different concentrations. Cells were collected and total protein was extracted to measure 187 
the expression of VEGFA, fibronectin and collagen IV. It was shown that both high 188 
glucose and AGE product were associated with promoted expressions of these proteins 189 
(Figure 3 A and B). Then the supernatant was collected to measure the concentrations 190 
of inflammatory factors by ELISA. Results showed that high glucose or AGE product 191 
stimulation resulted in increased release of inflammatory factors (Figure 3 C and D).  192 
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Fibrosis and inflammation was regulated by VEGFA in HPMCs 193 
To investigate the role of VEGFA on fibrosis and inflammation, we constructed the 194 
specific siRNA targeting VEGFA. Real-time PCR and western blotting showed high 195 
gene interference efficiency at protein level (Figure 4 A). SiRNA (or negativecontrol) 196 
was transfected into HPMCs before high glucose stimulation. Western blotting showed 197 
that the high glucose-induced expression of fibronectin and collagen IV was signifi-198 
cantly inhibited by siRNA transfection (Figure 4 B). Also, the over-expressed inflam-199 
matory factors were attenuated by the siRNA targeting VEGFA (Figure 4 C). As a whole, 200 
it was suggestive that VEGFA may play an important role in regulation of fibrosis and 201 
inflammation in HPMCs.  202 
MiR-15a-5p was the significantly down-regulated miRNA in HPMCs 203 
Several miRNAs have been reported elsewhere to regulate expression of VEGFA. Here 204 
we detected five of those. RT-PCR using supernatant of tissue showed that miR-15a-5p 205 
was the most significantly decreased one in PD patients compared with control (Figure 206 
5 A). Then cultured HPMCs were used as the in vitro model of PD to verify the expres-207 
sion of miR-15a-5p. Results showed that it also gradually decreased as the concentra-208 
tion of high glucose or AGE increased (Figure 5 B).  209 
MiR-15a-5p regulates VEGFA expression by directly binding to its mRNA 210 
Next we investigated whether over-expression of miR-15a-5p affect high glu-211 
cose/AGE-induced fibrosis and inflammation. MiRNA mimic specific for miR-15a-5p 212 
was constructed while vector was used as control. RT-PCR showed that miRNA mimic 213 
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efficiently increased the expression of miR-15a-5p in HPMCs cultured under a standard 214 
condition (Figure 6 A). Under high glucose or AGE product condition, miRNA mimic 215 
also restored the expression of miR-15a-5p. In both conditions, negative control 216 
showed no effect (Figure 6 B). Then RT-PCR showed that miR-15a-5p mimic signifi-217 
cantly restrained high glucose-induced VEGFA mRNA, suggesting the regulatory role 218 
of miR-15a-5p in VEGFA mRNA manipulation (Figure 6 C). We further explored the 219 
putative mechanism of miRNA-15a-5p-regulated VEGFA. Using Target Scan to predict 220 
the binding possibility, it was shown a strong putative binding site between 276 and 221 
283 in VEGFA 3’UTR region (Figure 6 D). To verify this binding effect, a dual-fluo-222 
rescence reporter system was constructed. HPMCs were co-transfected with miR-15a-223 
5p mimic and luciferase system containing wild type or mutant sequence of the pre-224 
dicted target binding sequence in VEGFA mRNA. Enzyme activity was measured, 225 
showing that over-expression of miR-15a-5p significantly decreased enzyme activity 226 
in the wild type group. However, such effect was eliminated in the mutant group (Figure 227 
6 E), indicating the identification of the binding sites. These results showed that miR-228 
15a-5p regulated VEGFA expression by directly binding to its mRNA. 229 
Over-expression of miR-15a-5p could inhibit VEGFA, fibrosis and inflammation 230 
in cultured HPMCs 231 
HPMCs were transfected with mimic or negative control before high glucose or high 232 
AGE product stimulation. Western blotting showed that both high glucose and AGE-233 
induced expression of VEGFA, fibronectin and collagen IV were significantly sup-234 
pressed by miRNA mimic (Figure 7). ELISA showed that the elevated concentration of 235 
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inflammatory factors in supernatant of cultured HPMCs was attenuated by transfection 236 
of mimic (Figure 8). All these results indicated that miR-15a-5p may play an important 237 
role in regulation of VEGFA, fibrosis and inflammation induced by either high glucose 238 
or AGE product. 239 
TGF-β1/Smad2 was the down-stream signaling pathway of miR-15a-5p/VEGFA 240 
The phosphorylation state of Smad2 was tested by western blot. Results showed that 241 
high glucose could activate Smad2 by increasing p-Smad2/Smad2 ratio. However, high 242 
glucose-induced activation of Smad2 was significantly attenuated by siRNA-VEGFA 243 
or miRNA-15a-5p mimic (P<0.05). What’s more, TGF-β1 could also promote phos-244 
phorylation of Smad2 (Figure 9). These results indicated that TGF-β1/Smad2 was an 245 
important down-stream signaling pathway of miR-15a-5p/VEGFA.DISCUSSION 246 
Long-term PD is a risk factor of peritoneal inflammation and fibrosis which is mainly 247 
caused by functional and morphological changes in peritoneal membrane. Continuous 248 
stimulation by high glucose and AGE product to mesothelial cells on the surface of 249 
peritoneal membrane would lead to membrane injury and dysfunction (Krediet et al., 250 
2000). In the current study, we observed that over-expressed VEGFA was positively 251 
correlated with increased fibrosis and inflammation in peritoneum of PD patients. The 252 
in vitro model, using high glucose or AGE -stimulated HPMCs, showed that VEGFA 253 
was the up-stream regulator of fibrosis and inflammatory factors. Among those putative 254 
miRNAs, which were reported to regulate VEGFA mRNA elsewhere, miR-15a-5p was 255 
the most significantly down-regulated one in peritoneum of PD patients. In cultured 256 
HPMCs, we found that miR-15a-5p could regulate VEGFA expression via directly 257 
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binding to its mRNA 3’UTR. Restoration of miR-15a-5p could inhibit inflammation 258 
and fibrosis of HPMCs. Further experiments showed that TGF-β1/Smad2 was activated 259 
by high glucose and regulated by miR-15a-5p and VEGFA. These results imply that 260 
miR-15a-5p plays its role via regulating VEGFA mRNA in HPMCs inflammation and 261 
fibrosis induced by long-term PD (Figure 10). 262 
VEGFA is the most ubiquitously and abundantly expressed member of VEGF family. 263 
Our previous studies have already confirmed that high glucose could promote VEGF 264 
expression in peritoneal tissue of PD Sprague-Dawley rats (Guo et al., 2014a; Xiao et 265 
al., 2014; Zhao et al., 2011). In the present study, we further tested the expression and 266 
function of VEGFA in patient samples and in vitro cultured HPMCs. In accordance 267 
with the animal studies, elevated VEGFA was showed to be closely related with in-268 
flammation and fibrosis in peritoneum of PD patients. In high glucose or AGE product 269 
-stimulated HPMCs, VEGFA was found to be an instigator of inflammation and fibrosis. 270 
Previous studies indicated that several miRNAs could bind and regulate VEGFA 271 
mRNA. However, their roles in PD have not been tested. Here, we detected five of 272 
those and results showed that miR-15a-5p was the most significantly down-regulated 273 
one. As a result, we focused on its role in VEGFA-mediated mesothelium dysfunction 274 
during PD. In cultured HPMCs, high glucose or AGE product inhibited expression of 275 
miR-15a-5p. When miRNA mimic was transfected into HPMCs to restore miR-15a-5p, 276 
it led to attenuation of over-expressed VEGFA.  277 
MiRNA-15a-5p has been reported to function via binding with different mRNAs in 278 
3’UTR. Previous studies have already confirmed CDKN2B, BCL2L2, AP4, and Bim-279 
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1 (Guo et al., 2014b) to be the target of miR-15a. Here, we also wondered whether miR-280 
15a-5p could target VEGFA mRNA. First, we searched Target Scan to predict the bind-281 
ing efficiency of these two molecules. Results showed an 8-mer paring sequence in 282 
3’UTR of VEGFA mRNA for miR-15a-5p. To confirm this prediction, we performed 283 
dual-luciferase reporter assay system and results showed that the enzyme activity was 284 
significantly reduced in existence of miR-15a-5p mimic, suggesting a binding effect 285 
via the predicted sequences.  286 
MiR-15a-5p has shown important roles in regulating cancer behavior by targeting mul-287 
tiple mRNAs (Alderman and Yang, 2016). Recently, some studies also documented its 288 
role in regulating inflammation and fibrosis. In bacterial sepsis model of mice, inflam-289 
mation at the initial phase of infections was associated with deletion of miR-15a (Moon 290 
et al., 2014). During this process, miR-15a was reported to control inflammation via 291 
limiting expression of Toll-like receptor 4 (TLR4) which is the receptor of innate im-292 
munity. MiR-15a is also an important participator in cellular and humoral immunity. It 293 
was reported that peripheral blood mononuclear cells isolated from patients of acute 294 
coronary syndrome expressed decreased level of miR-15a (Liu et al., 2014). And by 295 
binding to 3'-UTR of coactivator-associated arginine methyltransferase 1 (CARM1), 296 
miR-15a modulated the expression of CARM1 and its down-stream chemokines. These 297 
results suggested that miR-15a participated in different process of inflammation in dif-298 
ferent diseases. In our experiments, expression of miR-15a-5p was closely related with 299 
inflammatory factors, including IL-6, MCP-1, TGF-β1, IL-8, IL-17a and TNF-α. Up-300 
regulation of miR-15a-5p in HPMCs by miRNA mimic attenuated the concentration of 301 
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these inflammatory factors, indicating its role in regulating inflammation of mesothelial 302 
cells in PD. As for fibrosis, some studies have documented the anti-fibrotic role of miR-303 
15a. In diabetic heart, which is characterized by gradual myocardial fibrosis, biopsy 304 
tissues showed significant down-regulation of miR-15a with marked up-regulation of 305 
pro-fibrotic transforming growth factor-beta receptor-1 (TGFbetaR1) and connective 306 
tissue growth factor (CTGF). What’ more, therapeutic restoration of miR-15a in cardi-307 
omyocytes reduced the activation of TGFbetaR1 and CTGF and diminished the differ-308 
entiation of diabetic human cardiac fibroblasts (Rawal et al., 2017). Similarly, in Chla-309 
mydia infection of the reproductive epithelium, miR-15a was down-regulated and was 310 
responsible for the epithelial-mesenchyme transition which would lead to fibrosis 311 
(Igietseme et al., 2015). In accordance with these studies, our results also showed that 312 
restoration of miR-15a-5p in HPMCs by transfection of miRNA mimic could limit the 313 
over-expressed fibronectin and collagen IV. All these results suggested that miR-15a-314 
5p play an important role in regulating inflammation and fibrosis of mesothelial cells 315 
in PD. 316 
TGF-β1 was reported to be involved in many biological processes, including inflam-317 
mation and fibrosis. By binding to its specific transmembrane receptors, it could recruit 318 
and phosphorylate Smads which then translocate into the nucleus to regulate target gene 319 
expression. In proximal tubular epithelial cells, TGF-β1 activated Smad2 is responsible 320 
for the expression of fibronectin (Rhyu et al., 2005). In HPMCs, high glucose solution 321 
activated TGF-β1-dependent Smad2 and Smad4, which were involved in the fibrosis 322 
and functional injury of the peritoneum (Yang et al., 2007; Yao et al., 2004). In our 323 
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study, the results indicated that high glucose modulated phosphorylation state of Smad2 324 
partially by up-regulation of TGF-β1. This effect could be inhibited by siRNA targeting 325 
VEGFA or miR-15a-5p mimic suggesting miR-15a-5p/VEGFA was the up-stream reg-326 
ulator of TGF-β1/Smad2. The enhanced signaling pathway finally led to expression of 327 
fibrosis factors and failure of peritoneal ultrafiltration (Zhang et al., 2005). However, 328 
further studies are needed to test the involvement of other members of Smads family.In 329 
summary, our results demonstrate that miR-15a-5p is an important regulator of inflam-330 
mation and fibrosis via directly binding with 3’UTR of VEGFA mRNA in peritoneal 331 
mesothelial cells. TGF-β1/Smad2 is the down-stream signaling pathway of miR-15a-332 
5p/VEGFA. Targeting miR-15a-5p/VEGFA may provide us new strategies in preven-333 
tion and treatment of peritoneal fibrosis. 334 
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